Clinical and Forensic Toxicology News: June 2018

An AACC/CAP Educational Newsletter for Toxicology Laboratories
CFTN is registered with the U.S. Library of Congress, ISSN 2374-9679

Read the June 2018 issue of CFTN

Designer Benzodiazepines (page 1)

New Drugs Challenge Laboratories
Benzodiazepines are a class of drugs used as minor tranquilizers and are readily available on the illicit market. The current opioid crisis may be masking what could ultimately become a benzodiazepine epidemic.

Imatinib Mesylate (page 6)

Should Cancer Drug Be Added to the List of Therapeutic Drugs to Monitor?
Recent findings support the use of TDM for imatinib.

Fentanyl (page 8)

Common Drugs Used in Pregnancy Can Cause Positive Immunoassays
Fentanyl is a synthetic opioid analgesic used for management of chronic pain or in combination with sedative hypnotic agents for the induction of anesthesia. A commonly prescribed medication can result in a false-positive fentanyl immunoassay result.

Contaminated Synthetic Cannabinoids Lead to Deaths and Bleeding in Illinois (page 9)

The Illinois Department of Public Health has issued warnings about an outbreak of health problems and deaths linked to synthetic cannabinoids, some of which appear to contain the rat poison brodifacoum.

States Consider Laws to Ban the Sale of Fake Urine Used to Beat Drug Tests (page 10)

In response to the sale of “clean urine samples” in places like truck stops and over the internet, many states are considering legislation to ban the sale of fake urine, according to a recent report in the Washington Post.

Contact the editors with any comments or questions.